Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [BUSINESS]
2 clusters · 5 sources · 1 days · First seen · Last updated
Brazil medicinal cannabis market growth
Overview
The medicinal cannabis market in Brazil has experienced significant expansion in both revenue and patient numbers. By 2026, market revenue surpassed R$ 1.14 billion, marking a 17% increase from 2025. The patient population reached over 1.1 million people, a substantial rise from 430,000 in 2023, driven largely by declining product prices.
Access to treatment is distributed across several channels: individual importation authorized by Anvisa serves 41% of patients, pharmacies and drugstores account for 37%, and patient associations serve 22%. Additionally, medicinal cannabis cultivation in the country grew by 30% to 35 hectares.
Industry developments include the ExpoCannabis Brasil 2026 event, which focuses on regulation, scientific research, and industrial hemp. The event highlights regional initiatives such as the public medicinal cannabis clinic in Ribeirão Pires, which began providing free cannabis-based oils to residents in early 2025.
Entities
Anvisa · Brazil · São Paulo Expo · Kaya Mind · Guto Volpi
Timeline
-
[BUSINESS] 2 sourcesExpoCannabis Brasil 2026 focuses on medicinal cannabis and business expansion
ExpoCannabis Brasil 2026 in São Paulo brings together 344 exhibitors to discuss medicinal cannabis, regulation, and industry growth, highlighting Ribeirão Pires’ pioneering public clinic.
-
[BUSINESS] 3 sourcesBrazil medicinal cannabis market exceeds R$ 1 billion
Brazil's medicinal cannabis market hit R$ 1.14 billion in 2026, serving over 1.1 million patients following regulatory shifts and declining product costs.
Sources
brasil247.com · globorural.globo.com · jornalmaisnoticias.com.br · mst.org.br · panoramafarmaceutico.com.br